… clinical utility of serology assays for SARS-CoV-2, we will briefly address some of the latest
developments in clinical … be prohibitive to such a method the clinical setting, especially if the …

… , is currently evaluated for routine clinical use. We compared the SARS-CoV-2 antigen …
simultaneous routinely conducted RT-PCR analysis of SARS-CoV-2 orf1 RNA detection with the …

… We evaluated a SARS-CoV-2 antigen test, Espline® SARS-CoV-2 reagent, with reverse
transcription polymerase chain reaction (RT-PCR) as reference test, using 129 nasopharyngeal …

… T-cell responses to SARS-CoV-2 following natural infection and post-vaccination.
Furthermore, we discuss the potential clinical utility of measuring T-cell responses to SARS-CoV-2, …

… coronavirus 2 (SARS-CoV-2) is essential. This study assessed the clinical utility of the
quantitative Roche Elecsys ® Anti-SARS-CoV-2 S assay (ACOV2S) using samples from the 2019-…

… coronavirus disease 2019 (COVID-19) pandemic caused by human severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-… SARS-CoV-2 is a single-strand RNA virus with a rapid …

… SARS-CoV-2 RT-PCR-positive patients is vital for effective infection prevention and control
(IPC) practices. Here we evaluate the clinical utility of SARS-CoV-… clinical utility of SARS-CoV-…

… different types of immunosuppression or other clinical factors impact the immune response.
… SARS-CoV-2 immunity over time, serology testing technologies, and appropriate SARS-CoV…

… immunosuppression management decisions in persistently SARS-CoV-2 RNA PCR positive
… and clinical utility of using a LFIA that detects anti-spike antibodies to deliver SARS-CoV-2 …

… and discuss the clinical utility and limitations of the different serological assays. SARS-CoV-2…
Currently, studies about the antibody responses against SARS-CoV-2 and the clinical utility …